TSS
AVXL icon

Two Sigma Securities’s Anavex Life Sciences AVXL Stock Holding History

Two Sigma Securities’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-24,201
Closed -$74.3K – 1734
2026
Q1 		$74.3K Buy
24,201
+2,733
+13% +$11.8K 0.01% 1211
2025
Q4 		$76.4K Buy
+21,468
New +$132K 0.01% 1012
2019
Q2 		– Sell
-18,597
Closed -$57K – 2066
2019
Q1 		$57K Buy
+18,597
New +$44.4K ﹤0.01% 1608
2018
Q3 		– Sell
-10,382
Closed -$27K – 2572
2018
Q2 		$27K Buy
+10,382
New +$29K ﹤0.01% 2544
2018
Q1 		– Sell
-10,478
Closed -$34K – 2663
2017
Q4 		$34K Sell
10,478
-17,966
-63% -$70.7K ﹤0.01% 1578
2017
Q3 		$118K Buy
28,444
+14,895
+110% +$66.2K 0.01% 660
2017
Q2 		$72K Buy
13,549
+2,790
+26% +$16.1K 0.01% 687
2017
Q1 		$62K Buy
+10,759
New +$55.6K 0.01% 787

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Securities's AVXL Position: Q2 2026 in Review

Two Sigma Securities sold out of Anavex Life Sciences (AVXL) in Q2 2026, closing a stake of 24,201 shares — an estimated $74.3K sold.

Two Sigma Securities first reported a position in AVXL in Q1 2017 and held it in 8 quarters. The position peaked at $118K in Q3 2017. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • Two Sigma Securities reported no remaining Anavex Life Sciences position as of Q2 2026 after selling out during the quarter.
  • Two Sigma Securities sold 24,201 Anavex Life Sciences shares in Q2 2026, an estimated $74.3K.
  • Two Sigma Securities first reported a position in Anavex Life Sciences in Q1 2017 and held it in 8 quarters.
  • Two Sigma Securities's Anavex Life Sciences position peaked at $118K in Q3 2017.
  • 179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.